A master cancer gene hijacks a ‘molecular crowbar’ to make breast cancer cells invasive January 22, 2021
The price of a drug should be based on its therapeutic benefits – not just what the market will bear January 19, 2021
A master cancer gene hijacks a ‘molecular crowbar’ to make breast cancer cells invasive January 22, 2021
The price of a drug should be based on its therapeutic benefits – not just what the market will bear January 19, 2021
Conferences ASH 2019: Novel immunotherapy agent for multiple myeloma shows promising pre-clinical results December 11, 2019 Promising pre-clinical results using a bispecific T-cell engager (BiTE), an experimental immunotherapy agent to attack…